TARA

Conviction 38HealthcareScan · Mon, Aug 10, 2026

TARA$4.12+0.00%

ResistanceSupportVol 14

Vol MA14 455.34K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Protara Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.protaratx.com ↗

Price4.12

Change+0.00%

Gap-0.24%

Rel volume3.00×

Avg volume422.28K

Avg $ vol1.71M

SMA 204.04

SMA 504.07

SMA 2005.24

Price vs 50+1.13%

Price vs 200-21.37%

MA stackmixed

50/200 cross—

Supertrenddown · 4.40

RSI (14)53

MACD hist0.02

MACD crossbull · 4d

Stoch %K / %D85 / 83

ADX (14)12

+DI / −DI18 / 13

RSI divergence—

MACD divergence—

ATR %+4.33%

ADR %3.95%

52w high7.56

52w low3.03

From 52w high-45.50%

Above 52w low+35.97%

New 52w highNo

SqueezeOn · 21d

Bollinger width7.69%

%B0.77

Donchian pos67.25%

Donchian high4.29

Donchian low3.77

AVWAP (52w high)5.38

vs AVWAP high-23.35%

AVWAP (52w low)5.28

vs AVWAP low-21.92%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d3.00×

Avg vol (14d)455.34K

Avg vol (20d)422.28K

Avg $ vol (20d)1.71M

Market cap231.56M

RS 3m (vs SPY)-28.97%

RS 6m (vs SPY)-50.73%

RS line new highNo

Trend template2/8

Technical rank24.2

1 week+3.78%

1 month-4.63%

3 months-21.82%

6 months-38.05%

1 year+32.90%

YTD-23.42%

P/E-4.03

P/B1.28

P/S78.55

P/FCF-4.10

EPS-1.34

Div yield—

ROE-31.70%

ROA-29.93%

Debt/Eq0.00

Current15.69

EV/EBITDA-3.37

Gross margin—

Net margin—

Rev growth0.00%

EPS growth-28.80%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value216.82M

Revenue2.95M

Net income-17.78M

Gross profit—

Free cash flow-56.46M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out56.2M

Employees51

ListedFri, Jan 10, 2020

Free float45.86M

Float %88.8%

Short interest4.54M

Days to cover6.7d

Short volume55.5%

Squeeze score70 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction38 / 100

Pattern quality—

Tech rank24.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance4.43

Support3.77

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TARA

All disclosures →

No recent disclosed trades by Congress in TARA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TARA · 1 buy

Insider	Side	Shares	Value	Traded	Filed
BESHAR LUKE M Director · Stock Option (Right to Buy) · 2026-06-15	Grant	31K	—	2026-06-15	2026-06-16

SEC filings

EDGAR filings in TARA · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.